T Klopfenstein
Overview
Explore the profile of T Klopfenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zayet S, Klopfenstein T, Ursulescu N, Belfeki N, Gendrin V, Osman M
New Microbes New Infect
. 2021 May;
41:100888.
PMID: 33936745
Clinical descriptions about influenza-like illness in children seem non-specific during the co-circulation of SARS-CoV-2 and influenza. This paper aimed to summarize recent studies comparing clinical features and outcome, laboratory and...
2.
De Larminat V, Zayet S, Klopfenstein T, Idelcadi M
New Microbes New Infect
. 2021 Apr;
41:100875.
PMID: 33898045
Intrathecal baclofen therapy is commonly used for neurologically spastic patients. One of the major complications is hardware infection, which generally requires urgent removal of the pump and the intrathecal catheter,...
3.
Zayet S, Lang S, Ben Abdallah Y, Klopfenstein T, Gendrin V
New Microbes New Infect
. 2020 Dec;
38:100808.
PMID: 33299565
We report the case of a 68-year-old man with long-term receipt of steroid therapy who was diagnosed with cerebral abscesses and pulmonary nocardiosis. This patient displayed only respiratory symptoms. Confirmation...
4.
Zayet S, Gendrin V, Klopfenstein T
New Microbes New Infect
. 2020 Nov;
38:100815.
PMID: 33204429
We retrospectively reconstituted the history of evolution and onset of the main symptoms of COVID-19 in 70 patients ([29 males, 41%] with a mean age of 56.7 ± 19.3 [19-96]...
5.
Zayet S, Klopfenstein T, Mezher C, Gendrin V, Conrozier T, Ben Abdallah Y
New Microbes New Infect
. 2020 Oct;
38:100785.
PMID: 33072337
To our knowledge, Complications such as pneumomediastinum and/or pneumothorax during the course of COVID-19 remain rare and their mechanism is poorly described. We present a case of COVID-19 pneumonia associated...
6.
Klopfenstein T, Zayet S, Lohse A, Balblanc J, Badie J, Royer P, et al.
Med Mal Infect
. 2020 May;
50(5):397-400.
PMID: 32387320
Introduction: No therapy has yet proven effective in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. Method: We conducted a retrospective case-control study in the...
7.
Klopfenstein T, Kadiane-Oussou N, Toko L, Royer P, Lepiller Q, Gendrin V, et al.
Med Mal Infect
. 2020 Apr;
50(5):436-439.
PMID: 32305563
Background: Medical publications about anosmia with COVID-19 are scarce. We aimed to describe the prevalence and features of anosmia in COVID-19 patients. Methods: We retrospectively included COVID-19 patients with anosmia...
8.
Voitey M, Bouiller K, Chirouze C, Fournier D, Bozon F, Klopfenstein T
Med Mal Infect
. 2019 Nov;
50(5):423-427.
PMID: 31722861
Introduction: Little is known about the functional symptoms associated with Lyme borreliosis (LB) in Europe. We aimed to assess functional symptoms associated with presumed LB and to compare patients with...
9.
Winiszewski H, Daguindau E, Chaignat C, Piton G, Bouiller K, Lepiller Q, et al.
Med Mal Infect
. 2019 Sep;
50(3):300-302.
PMID: 31530415
No abstract available.
10.
Carlet C, Tachikart A, Bellanger A, Aubin F, Chirouze C, Klopfenstein T
Med Mal Infect
. 2019 Jul;
49(7):545-547.
PMID: 31351804
No abstract available.